MESO logo

MESO
Mesoblast limited.

5,260
Mkt Cap
$1.97B
Volume
115,563.00
52W High
$21.50
52W Low
$9.88
PE Ratio
-20.61
MESO Fundamentals
Price
$15.20
Prev Close
$14.98
Open
$15.11
50D MA
$15.05
Beta
1.50
Avg. Volume
228,065.83
EPS (Annual)
-$0.8443
P/B
3.41
Rev/Employee
$211,960.04
$1,281.89
Loading...
Loading...

About

Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
81

Frequently Asked Questions

What is Market Cap of Mesoblast Ltd - ADR?
What is the 52-week high for Mesoblast Ltd - ADR?
What is the 52-week low for Mesoblast Ltd - ADR?
What is Mesoblast Ltd - ADR stock price today?
What was Mesoblast Ltd - ADR stock price yesterday?
What is the PE ratio of Mesoblast Ltd - ADR?
What is the Price-to-Book ratio of Mesoblast Ltd - ADR?
What is the 50-day moving average of Mesoblast Ltd - ADR?
How many employees does Mesoblast Ltd - ADR have?

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available